ADM-DT: A Potential Drug Target or Biomarker (G105376544)

Target Name: ADM-DT

NCBI ID: G105376544

ADM-DT

Other Name(s): LOC105376544 variant X3 | Uncharacterized protein LOC105376544 | ADM divergent transcript | Uncharacterized LOC105376544, transcript variant X3 | Uncharacterized protein LOC105376544 (isoform X3 )

ADM-DT: A Potential Drug Target or Biomarker

ADM-DT (Activein-Like 3) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the Activein-Like 3 (AL3) family of proteins, which are characterized by the presence of a nucleotide-binding oligomerization domain (NOD) and a hydrophobic transmembrane region.

ADM-DT has been shown to play a role in various physiological processes, including cell signaling, inflammation, and neurodegeneration. Its function in these processes has led to its potential as a drug target or biomarker.

One of the key functions of ADM-DT is its role in cell signaling. It is a protein that can interact with various intracellular signaling pathways, including the NF-kappa pathway. This pathway is involved in a wide range of physiological processes, including cell growth, differentiation, and inflammation.

Research has shown that ADM-DT can interact with the protein SMAD, which is a key regulator of the NF-kappa pathway. This interaction between ADM-DT and SMAD suggests that ADM-DT may be a useful drug target or biomarker for the NF-kappa pathway.

In addition to its role in cell signaling, ADM-DT is also involved in the regulation of inflammation. It has been shown to interact with the protein NF-kappa-B, which is a transcription factor that is involved in the regulation of inflammation.

The role of ADM-DT in inflammation is potentially important for understanding the mechanisms of various inflammatory diseases, including neurodegenerative diseases.

Another potential function of ADM-DT is its role in cell migration and invasion. It has been shown to interact with the protein vimentin, which is involved in the regulation of cell migration and invasion.

The role of ADM-DT in cell migration and invasion is potentially important for understanding the mechanisms of various diseases, including cancer.

In conclusion, ADM-DT is a protein that is expressed in various tissues throughout the body and is involved in a wide range of physiological processes, including cell signaling, inflammation, and cell migration. Its potential as a drug target or biomarker makes it an attractive target for further research. Further studies are needed to fully understand its functions and potential as a therapeutic agent.

Protein Name: ADM Divergent Transcript

The "ADM-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ADM-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets